These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 169588)

  • 1. [Anti-nuclear antibodies in collagen diseases].
    Gintz B; Phelip X; Micouin C; Cabanel G
    Sem Hop; 1975 Feb; 51(9):573-80. PubMed ID: 169588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinucleolar antibodies. Their frequency and diagnostic association.
    Ritchie RF
    N Engl J Med; 1970 May; 282(21):1174-8. PubMed ID: 4909324
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunologic methods in the differential diagnosis of collagen diseases].
    Kalden JR
    Med Welt; 1975 Dec; 26(50):2242-7. PubMed ID: 765672
    [No Abstract]   [Full Text] [Related]  

  • 6. Hidden anti-nuclear antibodies in rheumatic diseases.
    Mach PS; Piatier D; Le Go A; Delbarre F
    Clin Exp Immunol; 1980 Feb; 39(2):538-43. PubMed ID: 6993073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antinuclear antibodies: immunological characteristics and clinical significance].
    Lemaire V; Cyna J; Ryckewaert A; Peltier AP
    Rev Rhum Mal Osteoartic; 1979 Jun; 46(6):383-7. PubMed ID: 315610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoallergic diseases. II].
    Feo F
    Minerva Med; 1978 Oct; 69(51):3546-9. PubMed ID: 83553
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immune diagnosis of collagen diseases].
    Sönnichsen N
    Z Arztl Fortbild (Jena); 1981 Jun; 75(11-12):519-21. PubMed ID: 6975540
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
    Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of anti-DNA antibodies by electroimmunodiffusion. Comparison of the results with the study of antinuclear factors by immunofluorescence].
    Delpech A; Delpech B; Laumonier R
    Sem Hop; 1975 Mar; 51(14):945-9. PubMed ID: 175459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 13. [The fall of blood complement level in pathology. Study of 50 cases].
    Kourilsky O; Peltier AP; de Sèze S
    Nouv Presse Med; 1972 Jul; 1(28):1883-8. PubMed ID: 4115492
    [No Abstract]   [Full Text] [Related]  

  • 14. [Autoantibodies in collagen diseases].
    Meyer O
    Ann Med Interne (Paris); 1986; 137(8):666-78. PubMed ID: 2436515
    [No Abstract]   [Full Text] [Related]  

  • 15. Variable reactivity of antinuclear immunoglobulins with cell nuclei of various origin and quality.
    Zitńan D; Cebecauer L
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):303-12. PubMed ID: 4921006
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 18. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD; Turner RA
    Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.